Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
4.150
+0.160 (4.01%)
Oct 8, 2025, 2:56 PM EDT - Market open

Zura Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Mar '22
Net Income
-67.76-52.4-60.36-28.08-46.91
Depreciation & Amortization
0.030.01---
Asset Writedown & Restructuring Costs
--27.3823.88-
Stock-Based Compensation
18.8416.89.660.36-
Other Operating Activities
3.935.213.15-1.3445
Change in Accounts Payable
3.564.215.944.090.23
Change in Other Net Operating Assets
-2.16-1.91-0.83-0.23-
Operating Cash Flow
-43.57-28.08-15.05-1.31-1.68
Capital Expenditures
-0.12-0.08---
Sale (Purchase) of Intangibles
--5-8-13.09-30
Investing Cash Flow
-0.12-5.08-8-13.09-30
Total Debt Issued
---8.29-
Short-Term Debt Repaid
---10--
Total Debt Repaid
---10--
Net Debt Issued (Repaid)
---108.29-
Issuance of Common Stock
11.1268.16120.61--
Repurchase of Common Stock
-0.35-0.32---
Other Financing Activities
-1.034210.69-3.09-
Financing Cash Flow
9.74109.84121.2916.1160
Net Cash Flow
-33.9576.6998.241.7128.32
Free Cash Flow
-43.69-28.15-15.05-1.31-1.68
Free Cash Flow Per Share
-0.48-0.38-0.46-5.75-
Levered Free Cash Flow
-24.32-24.76-25.08--
Unlevered Free Cash Flow
-24.32-24.76-25.08--
Change in Working Capital
1.392.315.123.860.23
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q